Methods |
RCT
Method of randomisation: using a table of random numbers, which was stratified by study centers and intent of treatment (curative or palliative)
Assessor blinding: yes
Participant blinding: no
Loss to follow‐up: 8/82 in the PRT group; 12/73 in the control group
Intention‐to‐treat analysis: yes
Post‐program follow up: no |
Participants |
Location: Canada
N = 155 (82 in PRT)
Sample: men with prostate cancer
Age: mean 68.2 years (SD = 7.9)
Inclusion criteria: had prostate cancer, would received androgen deprivation therapy for at least 3 months after recruitment, and the treating oncologist provided consent
Exclusion criteria: severe cardiac disease, uncontrolled hypertension, pain, unstable bone lesions, and residence more than 1 hr from the study center |
Interventions |
PRT versus control
1. PRT
Type of Ex: 6UL/3LL
Equipment: not reported
Intensity: 60‐70% of 1 RM, increased 5 lb after 12 successful repetitions
Frequency: Ex3
Reps/Sets: 8‐12/2
Duration: 12 weeks
Setting: fitness center
Supervision: full
Adherence: 79%
2. Control Group: on a waiting list, offered the identical exercise advice and guideline as the exercise group after the study period |
Outcomes |
Primary: Health‐related quality of life
Secondary: Muscle fatigue (Number of repetition)
Comments of adverse events: no |
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Allocation concealment? |
Unclear risk |
B ‐ Unclear |